Pembrolizumab
#
Find similar titles
- (rev. 3)
- Hyungyong Kim
Structured data
Pembrolizumab (formerly MK-3475 and Lambrolizumab, trade name Keytruda, 키트루다) is a humanized antibody used in Cancer immunotherapy. It blocks a protective mechanism on cancer cells, and allows the Immune system to destroy those cancer cells. It targets PD-1 receptor. (https://en.wikipedia.org/wiki/Pembrolizumab)
관련정보
- Keytruda – 범용 항암치료제의 등장인가
- 미 FDA, 조직과 무관한(tissue-independent) 항암제 신속승인 : 키트루다의 약물 사용 범위 확대
Incoming Links #
Related Articles (Article 0) #
Suggested Pages #
- 0.172 Cytokine release syndrome
- 0.071 CloudNeo
- 0.062 pVAC-Seq
- 0.032 Molecular and genetic properties of tumors associated with local immune cytolytic activity
- 0.025 B7-1
- 0.025 IDO
- 0.025 ASCO
- 0.025 Genome Medicine
- 0.025 Avelumab
- 0.025 April 19
- More suggestions...